Current Diabetes Reports

, Volume 11, Issue 2, pp 111–119 | Cite as

Protein Content in Diabetes Nutrition Plan

Article

Abstract

Medical nutrition therapy plays a major role in diabetes management. Macronutrient composition has been debated for a long time. However, there is increasing evidence that a modest increase in dietary protein intake above the current recommendation is a valid option toward better diabetes control, weight reduction, and improvement in blood pressure, lipid profile, and markers of inflammation. Increasing the absolute protein intake to 1.5–2 g/kg (or 20–30% of total caloric intake) during weight reduction has been suggested for overweight and obese patients with type 2 diabetes and normal kidney function. Increased protein intake does not increase plasma glucose, but increases the insulin response and results in a significant reduction in hemoglobin A1c. In addition, a higher dietary protein intake reduces hunger, improves satiety, increases thermogenesis, and limits lean muscle mass loss during weight reduction using a reduced calorie diet and increased physical activity. It is preferable to calculate protein intake for patients with diabetes as grams per kilogram of body weight and not as a fixed percentage of total energy intake to avoid protein malnutrition when a hypocaloric diet is used. The relationship between protein intake as grams per kilogram of body weight and albumin excretion rate is very weak, except in hypertensive patients and particularly in those with uncontrolled diabetes. A protein intake of 0.8–1 g/kg should be recommended only for patients with diabetes and chronic kidney disease. Other patients with diabetes should not reduce protein intake to less than 1 g/kg of body weight. This review discusses the effects of different amounts of protein intake in a diabetes meal plan. It particular, it discusses the effects of protein intake on renal function, the effects of protein content on diabetes control, and the effects of increased dietary protein on body weight.

Keywords

Medical nutrition therapy Diabetes Protein Nutrition 

Notes

Disclosure

Conflicts of interest: O. Hamdy: was on the advisory board of Abbott Nutrition; E.S. Horton: none.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Hockaday, T.D.R. (1981). Should the diabetic diet be based on carbohydrate or fat restriction? In M. Turner & B. Thomas (eds.). Nutrition and Diabetes. London : Libbey, 1981. pp23–32Google Scholar
  2. 2.
    Todhunter EN. Biographical notes from the history of nutrition: Elliott Proctor Joslin-June 6,1869–January 28,1962. J Am Diet Assoc. 1965;46:150.PubMedGoogle Scholar
  3. 3.
    • American Diabetes Association, Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, Franz MJ, Hoogwerf BJ, Lichtenstein AH, Mayer-Davis E, Mooradian AD, Wheeler ML. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008;31 Suppl 1:S61–78. This article describes the position statement of the American Diabetes Association regarding nutrition for patients with diabetes.PubMedGoogle Scholar
  4. 4.
    Raal FJ, Kalk WJ, Lawson M et al. Effect of moderate dietary protein restriction on the progression of overt diabetic nephropathy: a 6-month prospective study. American Journal of Clinical Nutr 1994; 60: 579–85.Google Scholar
  5. 5.
    Pedrini MT, Levey AS, Lau J et al. The effect of dietary protein restriction on the progression of diabetic and non-diabetic renal diseases: a meta analysis. Ann Intern Med 1996; 124: 627–32.PubMedGoogle Scholar
  6. 6.
    Kasiske BL, Lakatua JD, Ma JZ et al. A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis 1998; 31: 954–61.PubMedCrossRefGoogle Scholar
  7. 7.
    Pemerlalu J, Berdy M, Garrel ER et al. Effect of protein intake and glycaemic control on renal function in type 2 diabetes mellitus. Diabetology 1993; 36: 829–39.CrossRefGoogle Scholar
  8. 8.
    Parving HH. Renoprotection in diabetes: genetic and non-genetic risk factors and treatment. Diabetologia 1998; 41: 745–59.PubMedCrossRefGoogle Scholar
  9. 9.
    Bellizzi V et al. Very low protein diet supplemented with ketoanalogs improves blood pressure control I chronic kidney disease. Kidney Int. 2007;71(3):245–51PubMedCrossRefGoogle Scholar
  10. 10.
    Riley MD, Dwyer T. Microalbuminuria is positively associated with usual dietary saturated fat intake and negatively associated with usual dietary protein intake in people with insulin-dependent diabetes mellitus. Am J Clin Nutr. 1999;69(1):153.Google Scholar
  11. 11.
    Toelle M, Buyken A, Heitkamp G, Brämswig S, Mann J, Milne R, Gries FA, Keen H. Protein intake and urinary albumin excretion rates in the EURODIAB IDDM Complications Study. Diabetologia. 1997;40(10):1219–26.CrossRefGoogle Scholar
  12. 12.
    Knight EL, Stampfer MJ, Hankinson SE, Spiegelman D, Curhan GC. The impact of protein intake on renal function decline in women with normal renal function or mild renal insufficiency. Ann Intern Med. 2003;138(6):460–7PubMedGoogle Scholar
  13. 13.
    Möllsten AV, Dahlquist GG, Stattin EL, Rudberg S.Higher intakes of fish protein are related to a lower risk of microalbuminuria in young Swedish type 1 diabetic patients. Diabetes Care. 2001;24(5):805–10.PubMedCrossRefGoogle Scholar
  14. 14.
    • Azadbakht L, Atabak S, Esmaillzadeh A. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial. Diabetes Care. 2008;31(4):648–54. This longitudinal randomized trial shows the effect of plant protein on cardiorenal indices.PubMedCrossRefGoogle Scholar
  15. 15.
    Janney, NW. The metabolic relationship of the proteins to glucose. J Biol Chem. 1915;20:321–350.Google Scholar
  16. 16.
    MacLean, H. Modern Methods in the Diagnosis and Treatment of Glycosuria and Diabetes. 2nd edition. London, Constable & Co. Ltd.; 1924. pp. 1–52.Google Scholar
  17. 17.
    Krezowski, PA; Nuttall, FQ; Gannon, MC; Bartosh, NH. The effect of protein ingestion on the metabolic response to oral glucose in normal individuals. Am J Clin Nutr. 1986;44:847–856.PubMedGoogle Scholar
  18. 18.
    Nuttall, FQ; Mooradian, AD; Gannon, MC; Billington, CJ; Krezowski, PA. Effect of protein ingestion on the glucose and insulin response to a standardized oral glucose load. Diab Care. 1984;7:465–470.CrossRefGoogle Scholar
  19. 19.
    Khan, MA; Gannon, MC; Nuttall, FQ. Glucose appearance rate following protein ingestion in normal subjects. J Am Coll Nutr. 1992;11:701–706.PubMedGoogle Scholar
  20. 20.
    Gannon, MC; Nuttall, JA; Damberg, G; Gupta, V; Nuttall, FQ. Effect of protein ingestion on the glucose appearance rate in subjects with type 2 diabetes. J Clin Endo & Metab. 2001;86:1040–1047. doi:  10.1210/jc.86.3.1040.CrossRefGoogle Scholar
  21. 21.
    Gannon, MC; Nuttall, FQ; Neil, BJ; Westphal, SA. The insulin and glucose responses to meals of glucose plus various proteins in Type II diabetic subjects. Metabolism. 1988;37:1081–1088. doi:  10.1016/0026-0495(88)90072-8.PubMedCrossRefGoogle Scholar
  22. 22.
    Gannon, MC; Nuttall, FQ; Saeed, A; Jordan, K; Hoover, K. An increase in dietary protein improves the blood glucose response in people with type 2 diabetes. Amer J Clin Nutr. 2003;78:734–741.PubMedGoogle Scholar
  23. 23.
    Hamdy O, Ledbury S, Mullooly C, et al.: Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care 2003, 26:2119–2125.PubMedCrossRefGoogle Scholar
  24. 24.
    Pi-Sunyer X, Blackburn G, Brancati FL, et al.: Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care. 2007, 30:1374–1383.PubMedCrossRefGoogle Scholar
  25. 25.
    Sjöström CD, Lissner L, Wedel H, Sjöström L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res. 1999;7(5):477–84.PubMedGoogle Scholar
  26. 26.
    •• Hamdy O, Carver C. The Why WAIT Program: Improving Clinical Outcomes through Weight Management in Type 2 Diabetes. Curr Diab Rep. 2008; 8(5):413–20. This review describes several novel methods used for diabetes weight management in clinical practice.PubMedCrossRefGoogle Scholar
  27. 27.
    • Hamdy, O, Goebel-Fabbri A, Carver C, Arathuzik G, Shahar J, Capelson R, Beaton J, O’Donnell S, Elsayed N, Mitri J, Mentzelopoulos V, Abrahamson MJ. Why WAIT Program: A Novel Model for Diabetes Weight Management in Routine Clinical Practice. Obesity Management 2008;4(4):176–83. This study describes the results of the Why WAIT program for diabetes weight management in clinical practice that implemented a high protein dietary composition.CrossRefGoogle Scholar
  28. 28.
    Brinkworth GD, Noakes M, Parker B, Foster P, Clifton PM.Long-term effects of advice to consume a high-protein, low-fat diet, rather than a conventional weight-loss diet, in obese adults with type 2 diabetes: one-year follow-up of a randomised trial. Diabetologia. 2004;47(10):1677–86.PubMedCrossRefGoogle Scholar
  29. 29.
    Parker B, Noakes M, Luscombe N, Clifton P Effect of a high-protein, high-monounsaturated fat weight loss diet on glycemic control and lipid levels in type 2 diabetes. Diabetes Care. 2002;25(3):425–30.PubMedCrossRefGoogle Scholar
  30. 30.
    Paddon-Jones D, Westman E, Mattes RD, Wolfe RR, Astrup A, Westerterp-Plantenga M. Protein, weight management, and satiety. Am J Clin Nutr. 2008;87(5):1558S–1561S.PubMedGoogle Scholar
  31. 31.
    Luscombe ND, Clifton PM, Noakes M, Parker B, Wittert G.Effects of energy-restricted diets containing increased protein on weight loss, resting energy expenditure, and the thermic effect of feeding in type 2 diabetes. Diabetes Care. 2002;25(4):652–7.PubMedCrossRefGoogle Scholar
  32. 32.
    Leidy HJ, Carnell NS, Mattes RD, Campbell WW.Higher protein intake preserves lean mass and satiety with weight loss in pre-obese and obese women. Obesity 2007;15(2):421–9.PubMedCrossRefGoogle Scholar
  33. 33.
    Lejeune MP, Westerterp KR, Adam TC, Luscombe-Marsh ND, Westerterp-Plantenga MS. Ghrelin and glucagon-like peptide 1 concentrations, 24-h satiety, and energy and substrate metabolism during a high-protein diet and measured in a respiration chamber. Am J Clin Nutr. 2006;83(1):89–94.PubMedGoogle Scholar
  34. 34.
    Navarro-Diaz M, Serra A, Romero R, Bonet J, Bayés B, Homs M, Pérez N, Bonal J. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: Long-term follow-up. J Am Soc Nephrol. 2006;17(12 Suppl 3):S213–217.PubMedCrossRefGoogle Scholar
  35. 35.
    Skov AR, Toubro S, Bulow J, Krabbe K, Parving HH, Astrup A. Changes in renal function during weight loss induced by high vs lowprotein low-fat diets in overweight subjects. Int J Obes Relat Metab Disord. 1999;23:1170–1177.PubMedCrossRefGoogle Scholar
  36. 36.
    Brinkworth GD, Noakes M, Parker B, Foster P, Clifton PM. Long-term effects of advice to consume a high-protein, low-fat diet, rather than a conventional weight-loss diet, in obese adults with type 2 diabetes: One-year follow-up of a randomised trial. Diabetologia. 2004;47:1677–1686.PubMedCrossRefGoogle Scholar
  37. 37.
    Hamdy O, Elshebini A, Morsi A, Aboushady M, Mitri J, Elsayed N, Mentzelopoulos V, Abrahamson MJ. The Anti-Inflmmatory Effect of Weight Reduction in Obese Diabetic Patients after an Innovative 12-Week of Intensive Lifestyle Intervention. Diabetes (supplement 2). 2009; 731-PGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of Endocrinology, Harvard Medical SchoolJoslin Diabetes CenterBostonUSA

Personalised recommendations